BERNADETTE CONNAUGHTON

Corporate Board Profile

Tech Score: 0/100

← Back to All Directors

HALOZYME THERAPEUTICS, INC.

Filing Date Source Excerpt
2019-03-22 Bernadette Connaughton ... Age 60 ... Position with the Company: Director ... 2018 DIRECTOR COMPENSATION ... Bernadette Connaughton (3) ... Fees Earned or Paid in Cash($) 15,761 ... Stock Awards($) 100,011 ... Total($) 115,772
2020-03-20 Bernadette Connaughton ... 61 ... Director ... The current members of the Audit Committee are Jeffrey W. Henderson (Chair), Bernadette Connaughton, Kenneth J. Kelley and Mathew L. Posard. The current members of the Compensation Committee are Connie L. Matsui (Chair), Jean-Pierre Bizzari, Bernadette Connaughton and Jeffrey W. Henderson. 2019 DIRECTOR COMPENSATION ... Bernadette Connaughton ... Total($) 266,623
2021-03-26 Bernadette Connaughton622018Director ... The current members of the Compensation Committee are Bernadette Connaughton (Chair), Jeffrey W. Henderson and Kenneth J. Kelley. ... 2020 DIRECTOR COMPENSATION ... Bernadette Connaughton71,250200,021271,271
2022-03-25 Bernadette Connaughton (age 63) ... Board Committees: Compensation Committee (Chair) ... 2021 DIRECTOR COMPENSATION ... Bernadette Connaughton 70,000 250,046 320,046
2023-03-24 Bernadette Connaughton (age 64) ... Board Committees: Compensation Committee (Chair) ... Ms. Connaughton brings more than 30 years of global strategic, commercial and biopharmaceutical industry expertise ...
2024-03-15 Bernadette Connaughton (age 65) ... Board Committees: Compensation Committee (Chair) ... Bernadette Connaughton 70,000 150,002 250,015 470,017
2025-03-18 Bernadette Connaughton (age 66) ... Board Committees: Compensation Committee (Chair) ... The 2024 Director Compensation table shows Bernadette Connaughton ... Total($) 470,037.

Source material: SEC submissions metadata and DEF 14A proxy filings from EDGAR. Last updated: 2026-07-06